Bio Pharma Dive

DECEMBER 9, 2023

Study results disclosed at the American Society of Hematology meeting Saturday suggested potential for cell therapy in lupus and pointed out drug trial limitations.

Drug Trials 325

Drug Trials Trials Drugs 325

Bio Pharma Dive

OCTOBER 31, 2022

Bringing more diversity to clinical trials is a slow process and it takes time to get right. Learn how Worldwide Clinical Trials can diversify the reach of your orphan drug trial.

Clinical Trials 325

Clinical Trials Clinical Trials Drug Trials Trials 325

Bio Pharma Dive

DECEMBER 6, 2022

The decision not to run a Phase 3 trial of their medicine is the latest fallout from U.S. regulators’ recent moves to closely evaluate a class of drugs known as PI3 kinase inhibitors.

Drug Trials 173

Drug Trials Trials Drugs Regulation 173

Bio Pharma Dive

JANUARY 10, 2023

Moderna’s Stéphane Bancel and Pfizer’s Albert Bourla hinted Monday at greater dealmaking to come for their companies, while Gilead gave investors an update on an important cancer drug trial.

Trials 298

Trials Drug Trials Development Vaccination 298

pharmaphorum

JUNE 26, 2023

FDA sets out its thinking on psychedelic drug trials Phil.Taylor Mon, 26/06/2023 - 07:15 Bookmark this

Drug Trials 105

Drug Trials Trials Drugs 105

pharmaphorum

AUGUST 17, 2023

Abcuro raises $155m for KLRG1 drug trial Phil.Taylor Thu, 17/08/2023 - 14:54 Bookmark this

Drug Trials 97

Drug Trials Trials Drugs 97

Pharma Times

AUGUST 22, 2024

200,000 people in the UK have what is considered a ‘hidden’ lung condition

Drug Trials 158

Drug Trials Trials Drugs Research 158

Pharma Times

DECEMBER 4, 2020

LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19

Drug Trials 159

Drug Trials Trials Drugs 159

Pharma Times

SEPTEMBER 13, 2024

Innovative immunotherapy drug HTL0039732 shows potential in trials

Trials 137

Trials Drug Trials Drugs Research 137

pharmaphorum

MAY 19, 2022

Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies for patient monitoring, thanks to a new partnership with Empatica. The post Beckley adds digital element to its psychedelic drug trials appeared first on.

Drug Trials 105

Drug Trials Trials Drugs Development 105

Pharmaceutical Technology

OCTOBER 14, 2024

Digital assessment technologies continue to hold the potential to revolutionise pro-cognitive trials in schizophrenia.

Drug Trials 130

Drug Trials Trials Drugs 130

Bio Pharma Dive

MAY 24, 2022

The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10%.

Drug Trials 130

Drug Trials FDA Approval Trials Drugs 130

Pharma Times

AUGUST 15, 2024

Children accounted for the majority of mpox cases and deaths in the DRC since June 2023

Drug Trials 146

Drug Trials Vaccination Vaccine Trials 146

pharmaphorum

JANUARY 25, 2021

GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung cancer drug last week. The post GSK suffers another R&D setback, axing ulcerative colitis drug trial appeared first on.

Drug Trials 103

Drug Trials Trials Drugs Licensing 103

Pharmaceutical Technology

APRIL 16, 2024

The US FDA placed the clinical hold based on the preclinical data that showed that Neumora’s NMRA-266 triggered convulsions in rabbits.

Drug Trials 130

Drug Trials Trials Drugs 130

pharmaphorum

OCTOBER 27, 2020

US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury in severe COVID-19 patients, after concluding the safety of the combination was in doubt. Moreover, as an orally-active drug merimepodib could also have found a role outside the hospital setting.

Drug Trials 98

Drug Trials Trials Drugs Contract Manufacturing 98

pharmaphorum

DECEMBER 28, 2023

Cytokinetics rises on report that its aficamten drug improved symptoms in people with rare disease obstructive hypertrophic cardiomyopathy

Drug Trials 103

Drug Trials Drugs Trials 103

pharmaphorum

MAY 7, 2021

DMT is a powerful hallucinogenic drug found in several plants including the South American plant chacruna and when used recreationally is mixed with the ayahuasca plant to make the shamanic brew of the same name. The goal of the trial is for proof of concept of the drug as a wrap-around therapy for Major Depressive Disorder.

Drug Trials 98

Drug Trials Trials Marketing Drugs 98

STAT News

MARCH 29, 2023

Lupus is a disease long-plagued by failed clinical trials. And hopeful patients, many of them young women of color, are waiting — just three lupus drugs have been approved by the Food and Drug Administration in six decades. A key partnership is looking to change that.  

Drug Trials 116

Drug Trials Trials Drugs Engineer 116

Bio Pharma Dive

JULY 17, 2023

The results come about two years after negative findings from an earlier phase of the study, and position the company to seek an approval in transthyretin amyloidosis cardiomyopathy.

Drug Trials 130

Drug Trials Trials Drugs 130

BioSpace

JANUARY 28, 2021

Food and Drug Administration (FDA) has cleared an Investigational New Drug application that will allow Boston-based Vertex Pharmaceuticals to proceed with a clinical trial of its investigational stem cell-derived, fully differentiated pancreatic islet cell treatment for type 1 diabetes (.

Drug Trials 111

Drug Trials Trials Drugs Clinical Trials 111

BioPharma Reporter

OCTOBER 4, 2022

Kibow Biotech is celebrating its 25th anniversary as the company pivots toward developing a drug based on its proprietary probiotic strains that benefit kidney disease suffers.

Drug Trials 98

Drug Trials Drugs Trials Development 98

Scienmag

JANUARY 19, 2022

New research suggests manufacturers of newly developed antidepressant drugs have become more forthcoming about clinical trials that don’t pan out.

Trials 83

Trials Drug Trials Clinical Trials Clinical Trials 83

BioSpace

OCTOBER 11, 2020

was convicted on 47 counts of fraud and drug related charges on Oct. A 41-year-old man from Richland, Wash. 1, according to the U.S. Justice Department’s Eastern District of Washington.

Drug Trials 99

Drug Trials Drugs Trials 99

STAT News

FEBRUARY 17, 2023

Pfizer and partner Valneva are scrapping data from roughly half of the participants in a Phase 3 trial of a Lyme disease vaccine candidate after uncovering quality issues with a third-party clinical trial operator.

Trials 119

Trials Drug Trials Clinical Trials Clinical Trials 119

Scienmag

DECEMBER 20, 2021

A clinical trial in which two test drugs failed to help patients with mild COVID-19 nevertheless had a silver lining: It proved the viability of a study model in which a medication’s potential arrhythmic side effects are safely, effectively monitored without the participants ever setting foot in a hospital or clinic.

Drug Trials 79

Drug Trials Trials Drugs Clinical Trials 79

Medical Xpress

DECEMBER 29, 2022

A new drug designed to ward off Alzheimer's is being tested at more than 100 sites around the world, including the University of Pennsylvania.

Drug Trials 77

Drug Trials Drugs Trials Research 77

STAT News

MARCH 27, 2023

Food and Drug Administration proposed cancer drug developers in most cases conduct more rigorous trials to seek accelerated approval for their candidates , Reuters tells us. Meanwhile, we have been busy foraging for items of interest, which we hope will ease your journey today. We appreciate insightful tips. … The U.S.

Trials 98

Trials Drug Trials Drugs Clinical Trials 98

BioPharma Reporter

JULY 11, 2024

Amid a period of clinical holds and legal tangles, the US antibody specialist CytoDyn has reached a settlement to resolve legal disputes with its former contract research organization (CRO) Amarex Clinical Research.

Antibody 98

Antibody Drug Trials Clinical Research Trials 98

pharmaphorum

FEBRUARY 21, 2024

Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.

Clinical Research 129

Clinical Research Trials Research Drug Trials 129

Outsourcing Pharma

APRIL 6, 2023

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Drug Trials 98

Drug Trials Trials Clinical Trials Clinical Trials 98

BioSpace

FEBRUARY 15, 2021

According to a statement made by Cortexyme, the partial hold was placed on the development program for atuzaginstat after an FDA review of the trial data identified hepatic adverse events.

Drug Trials 88

Drug Trials Trials Drugs Development 88

pharmaphorum

FEBRUARY 10, 2025

Shares in Pliant plunged after the US biotech revealed that a safety signal led it to pause a trial of its idiopathic pulmonary fibrosis drug.

Drug Trials 66

Drug Trials Trials Drugs 66

World of DTC Marketing

APRIL 20, 2022

This was especially true with new drugs that have a significant competitive market. Trust in pharma did not decline, but they don’t want to be told about the data via charts; they want the ability to read the data for themselves and talk to other HCPs about the data and drug.

Marketing 218

Marketing Drugs Drug Trials Sales 218

pharmaphorum

AUGUST 4, 2020

Rare diseases drugs have always faced challenges when it comes to HTA approvals, even as governments bring in more regulatory policies that make their path through assessment easier. The results show that HTAs for orphan drugs can vary widely across Europe, causing inconsistencies in evidence requirements and recommendations.

Drugs 122

Drugs Manufacturing Marketing Regulation 122

BioPharma Reporter

JULY 4, 2023

Sosei Heptares has dosed the first subject in a phase 1 trial evaluating HTLâ149, a first-in-class GPR52 agonist, which represents a novel mechanism of action for the treatment of schizophrenia and related neurological diseases.

Drug Trials 78

Drug Trials Trials Drugs Development 78

STAT News

SEPTEMBER 22, 2022

Hello, everyone, and how are you today? A dank cloudy cover greeted us this morning, but we are ignoring the gloom by keeping busy. After all, there is much to be done. There are deadlines to meet, a variety of reading material to digest, and calls to make. We trust you can relate.

Drug Trials 98

Drug Trials Trials Drugs 98